Structural heart care
Structural heart care is the treatment of abnormalities of the heart's structure that may be formed at birth (congenital) or develop over time or because of disease.
Legacy Health's Structural Heart Program uses innovative, minimally invasive treatments to treat a broad range of conditions. We have a multi-disciplinary team approach that includes physicians from cardiology, interventional cardiology, cardiac surgery, cardiac imaging and cardiac anesthesia.
Our team of experts provide comprehensive and compassionate care for patients, often as an alternative to traditional open heart procedures. This means shorter procedure times, quicker hospital stays and faster recovery.
Stroke reduction in Atrial Fibrillation (AFib)
Some new devices may lower the risk for stroke and reduce or eliminate the need for blood thinners or anticoagulant medications. Legacy Health was the first Oregon health system to offer the Watchman device. For some patients, this can eliminate the need for blood thinning drugs. Find out more about the Watchman.
Minimally invasive aortic valve replacement
For patients with aortic valve stenosis, the TAVR procedure (transcatheter aortic valve replacement) is another minimally invasive procedure we offer as an alternative to open heart surgery. Patients work with a team of specialists including a cardiologist, heart surgeons and a valve clinic coordinator. Legacy Medical Group–Cardiology is one of just a handful of Portland clinics which offer the TAVR procedure.
Learn more about heart valve surgery.
Mitral valve treatment
For those patients with mitral valve regurgitation or mitral valve prolapse, for whom traditional surgery is too risky due to age or other health issues, the MitraClip is an option. The MitraClip was first implanted in 2003. In 2013, it was the FDA’s first approved alternative to mitral valve regurgitation surgery. The MitraClip is inserted through a catheter and guided through a vein in your leg. Once placed, the device works by allowing your mitral valve to close more completely and helps restore normal blood flow through to your heart.
Your age, your heart health, and your overall condition will be factors in determining whether the MitraClip will work for you. The average hospital stay is two to three days. Learn more on the MitraClip website.
Patent Forman Ovale (PFO)
A Patent Forman Ovale, or PFO, is a small opening between the two upper chambers of the heart. Normally, blood does not flow between these chambers. However, with a PFO, a small amount of blood can pass through the hole, creating an elevated risk for stroke. Learn more about PFO.
Treatment options include the implantation of the Amplatzer PFO Occluder device which was approved by the FDA in 2016. Legacy Health's Dr. Amish Desai was the first interventional cardiologist to use the Amplatzer device in the Northwest.
CardioMEMS Heart Failure System
For those with heart failure, tracking common symptoms is key to managing the disease. The CardioMEMs Heart Failure System is the first and only FDA-approved tool to help monitor symptoms, reduce hospital admissions and improve the quality of life for patients. One study found that hospitalizations were cut nearly in half
in the six months after the monitoring device was implanted in heart failure patients. Dr. Desai, an interventional cardiologist at Legacy, was the first to implant the monitoring device in the Northwest.
TAVR heart procedure gives patient another chance for life and love
READ MORE >
Watchman patient Barbara Reader: 'No blood thinners - less worry'
READ MORE >
Saving Jazmin's heart
READ MORE >